ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders

Berlin and Toronto, November11, 2019 ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, and Cyclica Inc., a leading biotechnology company that leverages artificial intelligence and computational biophysics to streamline the drug discovery process, have launched a joint venture aimed at changing the paradigm in which mental health disorders […]